2 results
Approved WMOWill not start
Primary ObjectiveSafety Lead-in* Evaluate the safety of a high-dose regimen of encorafenib + binimetinib combination therapy in patients with BRAFV600-mutant melanoma who have asymptomatic brain metastasisPhase 2If the high-dose regimen is…
Not approvedWill not start
To validate the method of measuring torsional eye movementsTo measure 3D eye movementsTo assess the age dependency of the responsesTo measure the gain of eye- versus headmovement and retinal slip velocity in clinical diagnosis by comparing patients…